JSC “Ventspils nafta” audited consolidated annual

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
JSC “Ventspils nafta” audited consolidated annual report 2014

JSC “Ventspils nafta” the holding company (VN) reduced loss in 2014 

JSC “Ventspils nafta” the holding company, made a loss of 5.28 million EUR in 2014 (2013: loss of 28.15 million EUR), largely as a result of a 9.67 million EUR impairment (2013: 47.32 million EUR) recognised in respect of VN’s investment in LatRosTrans Ltd. Net result for the reporting year was also affected by the 2.38 million EUR impairment of debt following changes in market value of real estate upon which this debt is secured. Dividend income from VN’s investment in Ventspils nafta terminals Ltd amounted to 6.37 million EUR.

Net interest income was 1.33 million EUR (2013: 1.19 million EUR). Administrative costs, which fell by approximately 200 thousand EUR to 952 thousand EUR (2013: 1.15 million EUR), are fully covered by management services provided to the Group and interest income from the issued loans and placed deposits. 

JSC “Ventspils nafta” and its subsidiaries (Group) performance results 

In 2014 the consolidated income of the Group fell by 3%, reaching 161.97 million EUR compared with the previous year, when it was 166.73 million. Net loss decreased from 61.21 million EUR in 2013 to 13.98 million EUR in 2014 meanwhile gross profit reached 42.56 million EUR that is 2.7% more than in 2013 when profit was 41.45 million EUR. 

2014 was a challenging year for the Group. In addition to the longer term issues facing the Group as Russia looks to rebalance the export of its petroleum products to domestic ports, geopolitical tensions added further uncertainty to the near-term outlook.

Results were impacted by the previously reported partial settlement of the Antonio Gramsi Corporation court case in the High Court of London which positively impacted financial results by 20.05 million USD as well as further impairments to the fleet, amounting to 55.25 million USD and a downwards re-evaluation of the investment in JSC Latvijas Naftas tranzīts of 8.34 million USD. The Group recognized an impairment of the crude oil infrastructure to the amount of 25.21 million EUR, following the displacement of the remaining technological crude oil from idle pipelines. The crude oil infrastructure now is fully impaired. The sale of the displaced crude oil generated one off gains in 2014 in the amount of 13.7 million EUR.

Financial results of VN Group in the audited report do not differ significantly from the unaudited report and are following:

Consolidated statement of income

    2014 2013
    EUR'000 EUR'000
       
Revenue   161 869 166 729
Cost of sales   (119 309) (125 277)
Gross profit   42 560 41 452
General and administrative expense   (10 974) (10 960)
Other operating income   38 091 1 689
Other operating expense   (11 052) (6 683)
Impairment of other non-financial assets   (71 189) (80 932)
Finance income   9 911 1 631
Finance costs   (7 524) (12 437)
Loss before tax   (10 177) (66 240)
Corporate income tax   (3 801) 5 026
Loss for the year   (13 978) (61 214)
       
Attributable to:      
   Parent company's shareholders   (7 611) (39 874)
   Non-controlling interest   (6 367) (21 340)
    (13 978) (61 214)
       
Loss per share (EUR per share) attributable     to the Parent company's shareholders:  (0.07)  (0.38)
Loss per share (EUR per share)    (0.13)  (0.59)

Key figures – financial indicators and ratios

  2010 2011 2012 2013 2014
Turnover (million EUR) 159.39 168.24 193.04 166.73 161.87
Net profit / (loss) (million EUR) (93.3) (17.34) 5.51 (61.21) (13.98)
Gross profit before depreciation (million EUR) % of turnover   56.27 35.3%   57.71 34.3%   72.08 37.3%   69.91 41.9%   63.85 39.4%
EBITDA (million EUR) % of turnover 34.22 21.5% 33.21 19.7% 57.37 29.7% 51.89 31.1% 59.41 37.0%
EBIT (million EUR) % of turnover (0.54) (0.3%) 1.57 0.9% 23.65 12.3% 23.45 14.1% 38.62 23.9%
Return on Assets (%) (10.4%) (1.9%) 0.6% (8.6%) (2.0%)
Return on Equity (%) (14.56%) (2.90%) 0.94% (11.16%) (2.84%)
EPS (EUR) (0.41) (0.10) 0.06 (0.38) (0.07)
Liquidity ratio 2.58 3.43 3.66 3.02 3.79
Dividends (EUR per share) - - - - - 

Attached: the VN Group audited annual report 2014, the VN parent company audited annual report 2014 and the Corporate governance report.

About JSC “Ventspils nafta”

JSC “Ventspils nafta” is one of the largest groups of companies in Latvia and works in the petroleum product transport, transhipment and storage, as well as shipping sector. JSC “Ventspils nafta” is the Group’s parent company, which manages investments in subsidiary companies, by promoting the Group’s joint values and growth in value of each individual company. 

JSC “Ventspils nafta” owns 51% in ““Ventspils nafta” terminals” Ltd, which is the largest crude oil and petroleum product terminal in the Baltics; 66% in “LatRosTrans” Ltd, which is the largest Latvian-Russian joint venture in the Baltics; 49.94% in JSC “Latvijas kuģniecība”, which is among the leading ship owners in the world in the medium-sized and handy tankers category.

Shares of JSC “Ventspils nafta” (NASDAQ OMX RIGA: VNF1R) are quoted in the Baltic Official List of the stock exchange NASDAQ OMX Riga since October 20, 1998.

         Further information:          Elīna Dobulāne, Communications Consultant          JSC “Ventspils nafta”          Phone: +371 25959447          Email: elina.dobulane@vnafta.lv          www.vnafta.lv

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 102

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 76

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Dallas College Recognition Signals Workforce Value

Updated Category News Views 63

Economic mobility rarely arrives with brass bands, but it can show up in a community-college ranking. Dallas College has landed on TIME and Statista's inaugural America’s Best Community Colleges 2027 list, one of 250 schools selected from roughly 1,100 nationwide. For a region that keeps talking about talent pipelines, this is a useful piece of outside validation—not...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 72

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 131

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading

Top 5 Most Recently Viewed Articles

Ross Gerber Expresses Optimism for Meta's Phone-Free Future

Updated Category News Views 242

Ross Gerber Praises Meta's Smart Glasses Technology Over the weekend, investor Ross Gerber expressed his admiration for Meta Platforms, Inc. (NASDAQ: META) smart glasses, affirming their potential to transform our relationship with technology. Gerber noted that this innovative eyewear gives him hope for a day when he might no longer rely on his smartphone. Smart Glasses:...

Continue Reading
Organ-on-a-Chip Market Insights and Future Projections

Updated Category News Views 118

Understanding the Organ-on-a-Chip Market Growth As technology evolves, the quest for more accurate and human-relevant drug testing models takes center stage. The Organ-on-a-Chip (OOC) market has emerged as a revolutionary force, previously valued at around USD 117.67 million, and now set to skyrocket to approximately USD 1.64 billion by 2032. This innovative approach is...

Continue Reading
Discovering Blue Light Cystoscopy Benefits in Bladder Cancer

Updated Category News Views 240

New Insights on Blue Light Cystoscopy and Bladder Cancer Photocure ASA, known as the Bladder Cancer Company, has made significant advancements in bladder cancer management with the recent study titled "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO Study." This research published in JU Open Plus provides compelling evidence...

Continue Reading
BioCryst's Bold Move: Astria Therapeutics Acquisition Insights

Updated Category News Views 211

BioCryst Enhances HAE Portfolio with Astria Acquisition BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has made a significant announcement regarding its acquisition of Astria Therapeutics, Inc. (NASDAQ: ATXS). This strategic move will strengthen BioCryst's position in the hereditary angioedema (HAE) market, as they plan to integrate Astria's promising therapies and...

Continue Reading
Milestone Scientific Reaches New Height with Strong Growth

Updated Category News Views 361

Milestone Scientific Achieves 52-Week High Milestone Scientific Inc. (NYSE: MLSS) has reached a significant milestone with its stock trading at $1.28, marking a 52-week high. This impressive achievement highlights the company's robust annual growth and increased investor confidence. As a result, the current market capitalization has reached approximately $97.37 million,...

Continue Reading